Apparent Diffusion Coefficient Histograms of Human Papillomavirus–Positive and Human Papillomavirus–Negative Head and Neck Squamous Cell Carcinoma: Assessment of Tumor Heterogeneity and Comparison with Histopathology

References

1. 1.↵
   2. Rampias T,
   3. Sasaki C,
   4. Psyrri A

   . Molecular mechanisms of HPV induced carcinogenesis in head and neck. Oral Oncol 2014;50:356–63 doi:10.1016/j.oraloncology.2013.07.011 pmid:23953776

   CrossRefPubMedWeb of Science
2. 2.↵
   2. Bishop JA,
   3. Lewis JS Jr.,
   4. Rocco JW, et al

   . HPV-related squamous cell carcinoma of the head and neck: An update on testing in routine pathology practice. Semin Diagn Pathol 2015;32:344–51 doi:10.1053/j.semdp.2015.02.013 pmid:25724476

   CrossRefPubMed
3. 3.↵
   2. Amin MB,
   3. Edge S,
   4. Greene F, et al

   . AJCC Cancer Staging Manual, 8th ed. New York: Springer-Verlag; 2017
4. 4.↵
   2. Salazar CR,
   3. Smith RV,
   4. Garg MK, et al

   . Human papillomavirus-associated head and neck squamous cell carcinoma survival: a comparison by tumor site and initial treatment. Head Neck Pathol 2014;8:77–87 doi:10.1007/s12105-013-0486-4 pmid:24002971

   CrossRefPubMed
5. 5.↵
   2. Hansson BG,
   3. Rosenquist K,
   4. Antonsson A, et al

   . Strong association between infection with human papillomavirus and oral and oropharyngeal squamous cell carcinoma: a population-based case-control study in southern Sweden. Acta Otolaryngol 2005;125:1337–44 doi:10.1080/00016480510043945 pmid:16303684

   CrossRefPubMed
6. 6.↵
   2. Duray A,
   3. Descamps G,
   4. Decaestecker C, et al

   . Human papillomavirus DNA strongly correlates with a poorer prognosis in oral cavity carcinoma. Laryngoscope 2012;122:1558–65 doi:10.1002/lary.23298 pmid:22532307

   CrossRefPubMed
7. 7.↵
   2. Goldenberg D,
   3. Begum S,
   4. Westra WH, et al

   . Cystic lymph node metastasis in patients with head and neck cancer: An HPV-associated phenomenon. Head Neck 2008;30:898–903 doi:10.1002/hed.20796 pmid:18383529

   CrossRefPubMed
8. 8.↵
   2. Byrd JK,
   3. Wilhoit CS,
   4. Fordham MT, et al

   . Predicting HPV status in head and neck cancer: the predictive value of sociodemographic and disease characteristics. Arch Otolaryngol Head Neck Surg 2012;138:1155–59 doi:10.1001/jamaoto.2013.850 pmid:23247234

   CrossRefPubMed
9. 9.↵
   2. Varoquaux A,
   3. Rager O,
   4. Dulguerov P, et al

   . Diffusion-weighted and PET/MR imaging after radiation therapy for malignant head and neck tumors. Radiographics 2015;35:1502–27 doi:10.1148/rg.2015140029 pmid:26252192

   CrossRefPubMed
10. 10.↵
    2. Varoquaux A,
    3. Rager O,
    4. Lovblad KO, et al

    . Functional imaging of head and neck squamous cell carcinoma with diffusion-weighted MRI and FDG PET/CT: quantitative analysis of ADC and SUV. Eur J Nucl Med Mol Imaging 2013;40:842–52 doi:10.1007/s00259-013-2351-9 pmid:23436068

    CrossRefPubMed
11. 11.↵
    2. Thoeny HC,
    3. De Keyzer F,
    4. King AD

    . Diffusion-weighted MR imaging in the head and neck. Radiology 2012;263:19–32 doi:10.1148/radiol.11101821 pmid:22438440

    CrossRefPubMed
12. 12.↵
    2. Nakahira M,
    3. Saito N,
    4. Yamaguchi H, et al

    . Use of quantitative diffusion-weighted magnetic resonance imaging to predict human papilloma virus status in patients with oropharyngeal squamous cell carcinoma. Eur Arch Otorhinolaryngol 2014;271:1219–25 doi:10.1007/s00405-013-2641-7 pmid:23880924

    CrossRefPubMed
13. 13.↵
    2. Kim S,
    3. Loevner L,
    4. Quon H, et al

    . Diffusion-weighted magnetic resonance imaging for predicting and detecting early response to chemoradiation therapy of squamous cell carcinomas of the head and neck. Clin Cancer Res 2009;15:986–94 doi:10.1158/1078-0432.CCR-08-1287 pmid:19188170

    Abstract/FREE Full Text
14. 14.↵
    2. Schouten CS,
    3. de Graaf P,
    4. Bloemena E, et al

    . Quantitative diffusion-weighted MRI parameters and human papillomavirus status in oropharyngeal squamous cell carcinoma. AJNR Am J Neuroradiol 2015;36:763–67 doi:10.3174/ajnr.A4271 pmid:25721078

    Abstract/FREE Full Text
15. 15.↵
    2. Just N

    . Improving tumour heterogeneity MRI assessment with histograms. Br J Cancer 2014;111:2205–13 doi:10.1038/bjc.2014.512 pmid:25268373

    CrossRefPubMed
16. 16.↵
    2. King AD,
    3. Chow KK,
    4. Yu KH, et al

    . Head and neck squamous cell carcinoma: diagnostic performance of diffusion-weighted MR imaging for the prediction of treatment response. Radiology 2013;266:531–38 doi:10.1148/radiol.12120167 pmid:23151830

    CrossRefPubMed
17. 17.↵
    2. Srinivasan A,
    3. Chenevert TL,
    4. Dwamena BA, et al

    . Utility of pretreatment mean apparent diffusion coefficient and apparent diffusion coefficient histograms in prediction of outcome to chemoradiation in head and neck squamous cell carcinoma. J Comput Assist Tomogr 2012;36:131–37 doi:10.1097/RCT.0b013e3182405435 pmid:22261783

    CrossRefPubMed
18. 18.↵
    2. Westra WH

    . The pathology of HPV-related head and neck cancer: implications for the diagnostic pathologist. Semin Diagn Pathol 2015;32:42–53 doi:10.1053/j.semdp.2015.02.023 pmid:25804343

    CrossRefPubMed
19. 19.↵
    2. Chernock RD

    . Morphologic features of conventional squamous cell carcinoma of the oropharynx: ‘keratinizing’ and ‘nonkeratinizing’ histologic types as the basis for a consistent classification system. Head Neck Pathol 2012;6 Suppl 1:S41–47 doi:10.1007/s12105-012-0373-4 pmid:22782222

    CrossRefPubMed
20. 20.↵
    R Core Team. R: A Language and Environment for Statistical Computing. The R Foundation for Statistical Computing. 2017. Available at: https://www.r-project.org/. Accessed January 24, 2017.
21. 21.↵
    2. Thomas J,
    3. Primeaux T

    . Is p16 immunohistochemistry a more cost-effective method for identification of human papilloma virus-associated head and neck squamous cell carcinoma? Ann Diagn Pathol 2012;16:91–99 doi:10.1016/j.anndiagpath.2011.09.002 pmid:22197546

    CrossRefPubMed
22. 22.↵
    2. Driessen JP,
    3. van Bemmel AJ,
    4. van Kempen PM, et al

    . Correlation of human papillomavirus status with apparent diffusion coefficient of diffusion-weighted MRI in head and neck squamous cell carcinomas. Head Neck 2016;38 Suppl 1:E613–18 doi:10.1002/hed.24051 pmid:25783872

    CrossRefPubMed
23. 23.↵
    2. Le Bihan D,
    3. Breton E,
    4. Lallemand D, et al

    . Separation of diffusion and perfusion in intravoxel incoherent motion MR imaging. Radiology 1988;168:497–505 doi:10.1148/radiology.168.2.3393671 pmid:3393671

    CrossRefPubMedWeb of Science
24. 24.↵
    2. Kim H,
    3. Choi SH,
    4. Kim JH, et al

    . Gliomas: application of cumulative histogram analysis of normalized cerebral blood volume on 3 T MRI to tumor grading. PloS One 2013;8:e63462 doi:10.1371/journal.pone.0063462 pmid:23704910

    CrossRefPubMed
25. 25.↵
    2. Ahn SJ,
    3. Choi SH,
    4. Kim YJ, et al

    . Histogram analysis of apparent diffusion coefficient map of standard and high B-value diffusion MR imaging in head and neck squamous cell carcinoma: a correlation study with histological grade. Acad Radiol 2012;19:1233–40 doi:10.1016/j.acra.2012.04.019 pmid:22818788

    CrossRefPubMed
26. 26.↵
    2. Shukla-Dave A,
    3. Lee NY,
    4. Jansen JF, et al

    . Dynamic contrast-enhanced magnetic resonance imaging as a predictor of outcome in head-and-neck squamous cell carcinoma patients with nodal metastases. Int J Radiat Oncol Biol Phys 2012;82:1837–44 doi:10.1016/j.ijrobp.2011.03.006 pmid:21601373

    CrossRefPubMed
27. 27.↵
    2. Porz N,
    3. Bauer S,
    4. Pica A, et al

    . Multi-modal glioblastoma segmentation: man versus machine. PloS One 2014;9:e96873 doi:10.1371/journal.pone.0096873 pmid:24804720

    CrossRefPubMed